Small Cell Lung Cancer Sclc Clinical Trials

ReadTheTrial indexes 2 studies for Small Cell Lung Cancer Sclc. The most common development stage is N/A (1 trials). Each trial page translates ClinicalTrials.gov eligibility, outcomes, and design into patient-friendly language so you can compare options quickly.

2 clinical trials found for Small Cell Lung Cancer Sclc.

Pipeline by Phase

PhaseTrialsDistribution
N/A 1
50%
Phase 3 1
50%

Trial Status Breakdown

Trials for Small Cell Lung Cancer Sclc

Real-World Data on the Treatment of Lung Cancer Patients With the Immune-Checkpoint Inhibitor Tislelizumab - the ReWoLuTe Study

NCT07510724 · RECRUITING · N/A

A GLOBAL PHASE 2/3 INTERVENTIONAL STUDY OF PF-08634404 IN COMBINATION WITH CHEMOTHERAPY IN PARTICIPANTS WITH EXTENSIVE STAGE SMALL CELL LUNG CANCER

NCT07226999 · RECRUITING · Phase 3

Frequently Asked Questions

What clinical trials are available for Small Cell Lung Cancer Sclc?

There are 2 clinical trials listed for Small Cell Lung Cancer Sclc. These span various phases from early safety studies to post-approval monitoring. Browse the trial listings below for details.

How do I find recruiting Small Cell Lung Cancer Sclc trials?

Look for trials with "Recruiting" status in the listings below, or visit our recruiting page to filter by condition. Each trial page includes decoded eligibility criteria to help you determine if you qualify.

What phases are Small Cell Lung Cancer Sclc trials in?

Current Small Cell Lung Cancer Sclc trials are distributed across: N/A (1), Phase 3 (1).

Find More Trials